These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Inhibition of the cytopathic effect by blockade of vaccinia virus DNA synthesis with 5-fluoro-2-deoxyuridine. Autoradiographic studies]. Henigst W; Pielsticker K Z Naturforsch B; 1968 Jan; 23(1):93-8. PubMed ID: 4387862 [No Abstract] [Full Text] [Related]
49. Synthesis of vaccinia viral proteins in cytoplasmic extracts. II. Identification of early and late viral proteins. Moss B; Katz E J Virol; 1969 Nov; 4(5):596-602. PubMed ID: 5360521 [TBL] [Abstract][Full Text] [Related]
50. Effect of cyclophosphamide in vitro and on vaccinia virus replication in tissue culture. Ginsberg AH; Monte WT; Johnson KP J Virol; 1977 Jan; 21(1):277-83. PubMed ID: 833925 [TBL] [Abstract][Full Text] [Related]
51. Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles. Katz E; Moss B J Virol; 1970 Dec; 6(6):717-26. PubMed ID: 4250367 [TBL] [Abstract][Full Text] [Related]
52. Temperature-sensitive events in the growth of variola virus in HeLa cells. Cruickshank JG; Bedson HS J Gen Virol; 1968 Sep; 3(2):255-66. PubMed ID: 4301635 [No Abstract] [Full Text] [Related]
53. Amino acid requirement of adenovirus multiplication. Wigand R; Kümel G J Gen Virol; 1978 May; 39(2):281-92. PubMed ID: 650177 [TBL] [Abstract][Full Text] [Related]
54. Reversible inhibition of poxvirus replication by cycloheximide during the early phase of infection. Chen X; Rösel J; Dunker R; Goldschmidt R; Maurer-Schultze B; Jungwirth C Virology; 1983 Jan; 124(2):308-17. PubMed ID: 6186078 [TBL] [Abstract][Full Text] [Related]
55. DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase. Bolkenius FN; Knödgen B; Seiler N Biochem J; 1990 Jun; 268(2):409-14. PubMed ID: 2363680 [TBL] [Abstract][Full Text] [Related]
56. Control of thymidine kinase synthesis in IHD vaccinia virus-infected thymidine kinase-deficient LM cells. Zaslavsky V; Yakobson E J Virol; 1975 Jul; 16(1):210-3. PubMed ID: 124355 [TBL] [Abstract][Full Text] [Related]
57. The effect of metabolic inhibitors on the production of vaccinia haemagglutinin. Aasen J; Haukenes G Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(2):246-50. PubMed ID: 4260757 [No Abstract] [Full Text] [Related]
58. Effect of 5-bromodeoxyuridine on vaccinia virus-induced polypeptide synthesis: selective inhibition of the synthesis of some post-replicative polypeptides. Pennington TH J Virol; 1976 Jun; 18(3):1131-3. PubMed ID: 1271530 [TBL] [Abstract][Full Text] [Related]
59. Uncoating of vaccinia virus. Zaslavsky V J Virol; 1985 Aug; 55(2):352-6. PubMed ID: 4020953 [TBL] [Abstract][Full Text] [Related]
60. Replication of vaccinia DNA in mouse L cells. IV. Protein synthesis and viral DNA replication. Esteban M; Holowczak JA Virology; 1978 May; 86(2):376-90. PubMed ID: 664237 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]